Edition:
United Kingdom

Savara Inc (SVRA.OQ)

SVRA.OQ on NASDAQ Stock Exchange Global Select Market

7.44USD
14 Dec 2018
Change (% chg)

$0.11 (+1.50%)
Prev Close
$7.33
Open
$7.31
Day's High
$7.56
Day's Low
$7.20
Volume
56,332
Avg. Vol
50,438
52-wk High
$17.11
52-wk Low
$7.05

Chart for

About

Savara Inc., formerly Mast Therapeutics, Inc., is an orphan lung disease company. The Company is engaged in the development and commercialization of novel therapeutics to address unmet medical needs. Its product pipeline include Molgradex, AeroVanc and Aironite. Molgradex is an inhaled formulation of recombinant human GM-CSF. It... (more)

Overall

Beta: 0.05
Market Cap(Mil.): $229.69
Shares Outstanding(Mil.): 24.20
Dividend: --
Yield (%): --

Financials

  SVRA.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -5.74 -- --
ROI: -43.82 9.01 14.96
ROE: -65.80 10.15 16.52

Earnings vs. Estimates